Conclusion Using nursing intervention was an effective method for raising the therapeutic compliance of patients with chronic hepatitis B.
结论护理干预可提高慢性乙型肝炎患者抗病毒治疗的依从性。
To observe the clinical effect and adverse effect of foscarnet sodium in treating patients with chronic severe hepatitis B.
目的探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效及其不良反应。
Methods: Blood samples of following were collected: 30 healthy persons, 30 chronic viral hepatitis B patients, and 60 chronic hepatitis B patients with deep jaundice.
方法：收集如下血标本：正常健康献血员30例，慢性乙型肝炎患者30例，慢性深度黄疸乙型肝炎患者60例。
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
抗病毒治疗应扩大到慢性乙肝和轻度丙氨酸转氨酶升高的患者吗？
Objective To evaluate the health beliefs in patients with chronic hepatitis-B and their relationship with patients' treatment compliance.
目的了解慢性乙型病毒性肝炎(慢性乙肝)患者的健康信念及其与治疗依从性的关系。
Patients with chronic hepatitis B developing lamivudine resistance are at high risk of disease progression and death.
对拉米夫定耐药的慢性乙肝患者面临着病情恶化甚至死亡的危险。
This paper sums up the experience in standardized follow-up visits through Internet to patients with chronic Type-B hepatitis.
介绍了网络规范化随访模式在慢性乙型病毒性肝炎感染者管理中的应用体会。
Objective to investigate the change of the insulin degrading enzyme activity of erythrocytes (EIDEA) in patients with chronic hepatitis b, and to reveal the ability of the liver for degrading insulin.
目的探讨慢性乙型肝炎(慢性乙肝)患者外周血红细胞胰岛素酶活性(EIDEA)的改变，以间接反映其肝脏胰岛素灭活功能的改变。
To assess the value of the model for end-stage liver disease (MELD) on the short-term prognosis in the patients with chronic liver failure (chronic and severe hepatitis B).
探讨终末期肝病模型(MELD)评分系统对预测慢性重型乙型病毒性肝炎患者短期预后的临床应用价值。
Objective: To investigate the effects of colon herbal dialysis in patients with chronic severe hepatitis b.
目的：观察中药结肠透析疗法对慢性重型肝炎的临床效果。
Results 8 healthy behaviors and 8 risky behaviors for the health of patients with chronic hepatitis B were improved obviously, showing a statistical meaning (P<0.01) .
结果慢性乙型肝炎患者8项健康行为和8项危险健康行为有明显改观，差异具有统计学意义（P<0.01）。
Method the body symptoms, the liver function and EPQ were measured in 150 patients with chronic hepatitis b.
方法：对150例慢性乙型肝炎患者进行症状自评、肝功能检测及艾森克测试。
Objective: To investigate the effect of hepatocyte growth-promoting factors injection (Weijia) in the treatment of hyperbilirubinemia in patients with chronic hepatitis B (CHB) .
目的：研究促肝细胞生长素注射液（威佳）在治疗慢性乙型肝炎（CHB）高胆红素血症中的作用。
Objective To explore the effect of Neuman systems model nursing process in nursing of patients with chronic hepatitis B.
目的探讨纽曼系统模式护理程序在慢性乙型肝炎患者护理中的作用。
Objective To investigate the affection of Adefovir dipivoxil on the serum fibrosis marks in patients with chronic hepatitis B.
目的探讨阿得福韦酯治疗慢性乙型肝炎对患者血清纤维化指标的影响。
Objective To study the demands of health education and explore the effective health educating models in patients with chronic type-B hepatitis.
目的调查慢性乙型肝炎病人健康教育需求情况，探讨有效的健康教育新模式。
Objective To study correlation factor and nursing strategy on noncompliance behavior of the patients with chronic hepatitis B, so as to improve the curative effect.
目的了解慢性乙型肝炎患者不遵从医嘱行为及相关因素，以采取相应护理措施，提高其治疗效果。
Objective To evaluate the clinical significance of serum soluble E-selectin and T-cell subpopulations in patients with chronic hepatitis B.
目的探讨慢性乙型肝炎患者血清可溶性E选择素和外周血T淋巴细胞亚群变化及其临床意义。
Objective To study the effect of compound fetal bovine liver extract tablets in combination with lamivudine on hepatic fibrosis in patients with chronic hepatitis B.
目的研究复方牛胎肝提取物联合拉米夫定对慢性乙型病毒性肝炎患者肝纤维化的影响。
Most of the patients with chronic liver diseases were infected with hepatitis B virus (HBV).
慢性肝病患者绝大多数已被乙型肝炎病毒(HBV)感染。
Methods: 70 patients with chronic severe hepatitis B were divided at random into therapeutic group and control group.
方法：70例慢性重型肝炎患者，随机分成治疗组及对照组。
These changes suggest that hepatic microcirculation disorders exist in patients with chronic hepatitis B and hepatic microcirculation structures disappear in cirrhotic livers.
提示慢乙肝患者存在肝脏微循环障碍，肝硬化时肝脏微循环结构丧失。
Methods 36 patients with chronic severe hepatitis B were randomly divided into 2 groups.
方法36例慢性重型乙型肝炎患者随机分为2组。
Method: 60 patients with chronic hepatitis Virus B were randomly divided into two groups, 32 in treating group and 28 in control group.
研究方法：我们将60例慢性乙型肝炎患者随机分为2组，治疗组32例，对照组28例。
The subjects of in vivo study were patients with chronic hepatitis B.
临床研究对象是慢性乙型肝炎患者。
The united mutations often occurred in patients with severe chronic hepatitis B, and been not related to the viral load.
联合变异株主要见于重度慢性乙型肝炎患者，与血清病毒含量无关。
To study mechanism of relationship HBV gene mutation in chronic hepatitis B patients with TCM syndrome.
研究慢性乙型肝炎患者HBV前C区基因变异的变化规律与中医证候的相关机制。
The specific cellular immunity was stronger in the patients with acute hepatitis B than in those with chronic hepatitis B and liver cirrhosis.
急性乙肝患者特异性细胞免疫功能明显强于慢性乙肝患者及肝炎肝硬化患者。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
早期的研究已经显示，对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后，获得了临床上的改善。
Methods 185 patients with chronic hepatitis B were undertaken ultrasonic examination of type B and histopathological staging as S1~S4 of the liver biopsies.
方法对185例慢性乙型肝炎患者肝脾进行超声检查，肝活检组织进行纤维化分期（S1～S4）。
应用推荐